ZCT.V Zero Candida Technologies Inc.

Healthcare Medical Devices TSX Venture Exchange
0.1400 CAD
Close of Nov 7, 2026
0.1100 0.2800
Market cap
CAD 2.73M
P/E
-
P/B
2.97x
ROE
-74.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is ZCT.V undervalued?

Graham number

The Graham number of Zero Candida Technologies Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Zero Candida Technologies Inc. fundamental analysis

No fundamental analysis for Zero Candida Technologies Inc. yet.

Zero Candida Technologies Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Zero Candida Technologies Inc.

Zero Candida Technologies, Inc., a technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis. It offers Zero Candida, a smart vaginal diagnostic device that collects and transmits treatment data to the attending physician in real time for assessment, treatment, personalization, and monitoring. The company is headquartered in Vancouver, Canada.

Full company profile